Literature DB >> 31606867

When a Pathological Forearm Fracture Led to Explore the Neck: About a Case.

Cyrille Buisset1, Léa Demarquet2, Marie Raynal3, Hélène Busby4, Claire Nominé-Criqui5, Laurent Brunaud5.   

Abstract

The majority of patients with parathyroid carcinoma (PC) have significant clinical signs and simultaneous symptoms related to the unregulated hypersecretion of parathyroid hormone (PTH) by the tumor. The aim of this case was to report a patient presenting an isolated bone fracture leading to the diagnosis of PC. A 20-years-old female patient presenting a fracture of both bones of the forearm following a fall from her own height. Imageries showed diffuse bone demineralization. Biology revealed malignant hypercalcemia at 4.1 mmol/L and PTH at 1331 pg/mL. Bone densitometry showed severe osteoporosis with a femoral and lumbar T-score < - 3DS. Imageries showed a right parathyroid mass of 32 mm. An one-piece excision of the pathological gland, right thyroid lobectomy and ipsilateral central lymph node dissection were performed. Postoperatively, the patient presented a hungry bone syndrome with severe hypocalcemia and required substitutive treatment. PTH on day 1 was normal. Pathology analysis found a PC with Ki67 at 3%, lymph node removal was negative. Complete one-piece surgical excision is the only potentially curative treatment for PC. Preoperative suspicion and intraoperative recognition of malignant features is important in order to propose an appropriate compartmental surgery, which can provide the lowest possible recurrence rate.

Entities:  

Keywords:  Parathyroid carcinoma; Pathological fracture; Primary hyperparathyroidism; Surgery

Mesh:

Year:  2019        PMID: 31606867      PMCID: PMC7413925          DOI: 10.1007/s12105-019-01085-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  5 in total

1.  Parathyroid carcinoma: a diagnostic and therapeutic challenge.

Authors:  A R Shaha; J P Shah
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

2.  Parathyroid carcinoma: a 43-year outcome and survival analysis.

Authors:  Avital Harari; Avantika Waring; Gustavo Fernandez-Ranvier; Jimmy Hwang; Insoo Suh; Elliot Mitmaker; Wen Shen; Jessica Gosnell; Quan-Yang Duh; Orlo Clark
Journal:  J Clin Endocrinol Metab       Date:  2011-09-21       Impact factor: 5.958

3.  Human chorionic gonadotropin measurements in parathyroid carcinoma.

Authors:  Mishaela R Rubin; John P Bilezikian; Steven Birken; Shonni J Silverberg
Journal:  Eur J Endocrinol       Date:  2008-07-14       Impact factor: 6.664

4.  The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform.

Authors:  Etienne Cavalier; Daniela Betea; Marie-Louise Schleck; Romy Gadisseur; Laurent Vroonen; Pierre Delanaye; Adrian F Daly; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

5.  Parathyroid carcinoma: a 22-year experience.

Authors:  Naifa L Busaidy; Camilo Jimenez; Mouhammed Amir Habra; Pamela N Schultz; Adel K El-Naggar; Gary L Clayman; Joshua A Asper; Eduardo M Diaz; Douglas B Evans; Robert F Gagel; Adam Garden; Ana O Hoff; Jeffrey E Lee; William H Morrison; David I Rosenthal; Steven I Sherman; Erich M Sturgis; Steven G Waguespack; Randal S Weber; Kelly Wirfel; Rena Vassilopoulou-Sellin
Journal:  Head Neck       Date:  2004-08       Impact factor: 3.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.